Most breast MRIs use intravenous contrast (gadolinium) because contrast-enhanced MRI is far more sensitive for detecting and characterizing breast lesions; it’s the standard for screening high‑risk women and assessing extent or treatment response. Non‑contrast techniques (e.g., diffusion-weighted MRI) exist for those who can’t receive gadolinium, but they’re less sensitive. Discuss risks, kidney function, and alternatives with your clinician.

A breast MRI with contrast is generally not painful. You lie still in the scanner; the contrast injection may cause a brief sting or warm flushing. Some people feel pressure from the breast coil, mild discomfort from lying face-down, or a pinch from the IV. Claustrophobia or anxiety can make it feel uncomfortable. Serious reactions are rare, and staff monitor you throughout.

Costs vary by country and setting. In the United States a breast MRI with contrast typically costs about $1,000–3,000 (higher at some centers; insurance often covers much or all). In the United Kingdom it’s generally provided free on the NHS; private scans run roughly £350–£900. In India expect about ₹4,000–20,000 depending on city and equipment.

Breast MRI uses an intravenous gadolinium‑based contrast agent (gadolinium chelates). These agents enhance blood flow and tissue differences, helping detect and characterize tumors and vascular lesions. Clinicians screen for pregnancy and assess kidney function (e.g., eGFR) beforehand because gadolinium carries small risks, particularly in severe renal impairment; allergic reactions are uncommon but possible.

A breast MRI without contrast typically takes about 20–40 minutes, though some exams may be as short as 15 minutes or as long as 45 minutes. Total time depends on scanner strength, number of image sequences, whether one or both breasts are scanned, and patient setup/positioning. It’s usually shorter than a contrast-enhanced MRI because dynamic contrast sequences aren’t performed.

Contrast is not mandatory for MRI. Most scans are done without it; gadolinium contrast is used selectively when it improves detection or characterization of tumors, inflammation, infection, or vascular abnormalities. The need is determined by the clinical question, prior imaging, and patient factors (kidney function, allergy history). Because of small risks, contrast is used only when expected benefits outweigh them.